Independently tested/Batch-level documentation
Batch record

BLD-501

CJC-1295 No DAC/Ipamorelin · View product

Product
CJC-1295 No DAC/Ipamorelin
Batch number
BLD-501
Date tested
November 5, 2026
Testing laboratory
Peptide Test Canada / Side-Chain Analytics Inc.
Identity result
Reported components: CJC-1295 No DAC and Ipamorelin (HPLC-MS/MS).
Quantity result
CJC-1295: 5.78 mg; Ipamorelin: 6.25 mg; laboratory-reported total net content: 12.04 mg (tested sample).
Purity result
CJC-1295: 99.85%; Ipamorelin: 99.89% chromatographic purity (tested sample).
Additional testing
No endotoxin or sterility results supplied.
Tests performed
HPLC-MS/MS identity analysis, Quantitative peptide content, Chromatographic purity

Laboratory sample ID BLD-501; report COA-2026-SC-04743; verification reference PTC-K487EXBD. Received October 29, 2026; analyzed and reported November 5, 2026. This record uses the laboratory sample ID, not a confirmed inventory lot number. Total net content is reproduced as reported by the laboratory; displayed rounded component values sum to 12.03 mg. Results apply only to the sample as received, not other vials or any entire lot or batch. They do not establish safety, efficacy, regulatory compliance, or suitability for human or veterinary use. Laboratory permission to display the full report was confirmed by the owner.

Analytical results describe only the sample tested by the named laboratory on the stated date, not other vials or an entire lot or batch. Endotoxin testing is not a sterility test. These results do not establish safety, efficacy, regulatory compliance, or suitability for human or veterinary use.